Noah Weiss litigates high-stakes civil and criminal matters for major corporations, public officials, sports leagues, senior executives, and high-net-worth individuals facing their most consequential disputes.
Noah maintains a broad civil practice in federal and state courts, as well as before arbitration panels. He has represented both plaintiffs and defendants in a wide range of substantive areas, including complex commercial disputes, financial services litigation, trust and fiduciary duty claims, partnership disputes, securities cases, sports and media rights, and construction litigation.
Noah has extensive experience representing clients across a range of complex international and cross-border matters. He regularly represents companies and individuals in international economic sanctions matters before the Department of the Treasury’s Office of Foreign Assets Control — including in enforcement defense, delisting petitions, licensing, and asset unblocking — as well as related Department of Justice matters. He has also represented clients in international commercial arbitration, including multiple ICC arbitrations, and in Section 1782 proceedings in aid of foreign litigation.
In criminal and investigations cases, Noah has guided clients through matters brought by the Department of Justice, the Securities and Exchange Commission, the U.S. Congress, and state and local authorities. He has handled matters involving healthcare fraud, the False Claims Act and Anti-Kickback Statute, the Foreign Corrupt Practices Act, and a broad range of other compliance and whistleblower allegations.
While an associate at the firm, Noah was seconded in-house at Medtronic, Inc. working on government and internal investigations.
Born and raised in Los Angeles, California, Noah graduated summa cum laude from the University of Pennsylvania and cum laude from Harvard Law School, where he was a Notes Editor on the Harvard Law Review and won the Ames Moot Court Competition. Before joining the firm, he clerked for the Honorable Thomas M. Hardiman on the United States Court of Appeals for the Third Circuit.
Representative Experience
Though all cases vary, and none is predictive, Noah’s experience includes:
- Representation of numerous individuals and entities before OFAC and DOJ in economic sanctions matters, including enforcement defense, delisting petitions, licensing, and asset unblocking proceedings
- Representation of the beneficiary of a billion-dollar trust in multiple matters related to the trust’s administration, including litigation of breach of fiduciary duty claims against trustees and matters related to the sale of a professional American sports franchise
- Representation of a major international bank in securities litigation, obtaining complete dismissal of claims alleging over $500 million in damages
- Representation of a multinational pharmaceutical company in Section 1782 proceedings in aid of foreign patent infringement litigation
- Representation of an LNG producer in multiple ICC arbitrations concerning the development of an LNG production facility in the United States
- Representation of a major American sports league in litigation concerning telecast rights
- Representation of a major American sports league in a congressional investigation
- Representation of an AmLaw 100 law firm in disputes related to departed partners, litigation funding arrangements, and related commercial matters
- Representation of a former partner in a private equity firm in a compensation dispute with his former firm
- Representation of a major construction firm in complex litigation against multiple subcontractors arising out of federal government projects in the Washington, DC area
- Representation of a multinational pharmaceutical company in a joint civil and criminal investigation
- Representation of a global financial institution in a series of RMBS-related litigations arising from its role as a securitization trustee
- Representation of a foreign entity in Section 1782 proceedings in aid of foreign breach of contract litigation
- Representation of a publicly traded company accused of overcharging a municipal government; on the final business day before a three-week jury trial was scheduled to begin, the plaintiff voluntarily dismissed all claims with prejudice with no payment by the client
- Representation of a global medical device corporation in a contract dispute with the former shareholders of an acquired company
- Representation of the former CEO of a Fortune 25 company in a joint DOJ-SEC investigation involving the Foreign Corrupt Practices Act
- Representation of a national medical device company in a healthcare fraud investigation
- Representation of a Fortune 500 corporation in qui tam False Claims Act litigation in California federal and state courts, resolved after years of litigation through complex settlements